Study of Osimertinib With and Without Ramucirumab in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Hoosier Cancer Research Network
Hoosier Cancer Research Network
Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Technische Universität Dresden
Washington University School of Medicine
M.D. Anderson Cancer Center
Norwegian University of Science and Technology
Ohio State University Comprehensive Cancer Center
Duke University
Georgetown University
Wake Forest University Health Sciences
University Hospitals Coventry and Warwickshire NHS Trust
M.D. Anderson Cancer Center
Guangdong Association of Clinical Trials
Instituto Nacional de Cancerologia de Mexico
Memorial Sloan Kettering Cancer Center
Washington University School of Medicine
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
Swiss Cancer Institute
University Hospital Heidelberg
H. Lee Moffitt Cancer Center and Research Institute
University of Oklahoma
Abramson Cancer Center at Penn Medicine
University of California, San Francisco
Mayo Clinic
Massachusetts General Hospital
Massachusetts General Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Massachusetts General Hospital
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Vanderbilt-Ingram Cancer Center
Fudan University
University of Iowa
City of Hope Medical Center
Wake Forest University Health Sciences
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
Fudan University
Centre Jean Perrin
Brigham and Women's Hospital
Brigham and Women's Hospital